MF
EW icon

Manchester Financial’s Edwards Lifesciences EW Stock Holding History

Manchester Financial’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-42
Closed -$4K – 720
2020
Q4 		$4K Buy
+42
New +$3.48K ﹤0.01% 474
2020
Q3 		– Sell
-240
Closed -$17K – 568
2020
Q2 		$17K Hold
240
– – 0.01% 253
2020
Q1 		$15K Sell
240
-90
-27% -$6.49K 0.01% 247
2019
Q4 		$26K Buy
+330
New +$25.8K 0.01% 226
2019
Q3 		– Sell
-240
Closed -$15K – 172
2019
Q2 		$15K Buy
+240
New +$14.5K 0.01% 279

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Manchester Financial's EW Position: Q1 2021 in Review

Manchester Financial sold out of Edwards Lifesciences (EW) in Q1 2021, closing a stake of 42 shares — an estimated $4K sold.

Manchester Financial first reported a position in EW in Q2 2019 and held it in 5 quarters. The position peaked at $26K in Q4 2019. 1,143 funds tracked by Wall St. Rank hold EW as of Q1 2021.

  • Manchester Financial reported no remaining Edwards Lifesciences position as of Q1 2021 after selling out during the quarter.
  • Manchester Financial sold 42 Edwards Lifesciences shares in Q1 2021, an estimated $4K.
  • Manchester Financial first reported a position in Edwards Lifesciences in Q2 2019 and held it in 5 quarters.
  • Manchester Financial's Edwards Lifesciences position peaked at $26K in Q4 2019.
  • 1,143 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2021.

Based on Manchester Financial's 13F filing for Q1 2021, filed 3 May 2021.